UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis

Proceedings of the National Academy of Sciences - PNAS, 2016-01, Vol.113 (3), p.704-709

2016

Volltextzugriff (PDF)

Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications

JNCI : Journal of the National Cancer Institute, 2018-10, Vol.110 (10), p.1102-1114

2018

Volltextzugriff (PDF)

Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2

Frontiers in oncology, 2021-01, Vol.10, p.627463-627463

2021

Volltextzugriff (PDF)

Nuclear localization of heparanase 2 (Hpa2) attenuates breast carcinoma growth and metastasis

Cell death & disease, 2024-03, Vol.15 (3), p.232-232, Article 232

2024

Volltextzugriff (PDF)

Heparanase facilitates cell adhesion and spreading by clustering of cell surface heparan sulfate proteoglycans

PloS one, 2008-06, Vol.3 (6), p.e2319-e2319

2008

Volltextzugriff (PDF)

The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growth, Associating with Increased p21 Expression

Neoplasia (New York, N.Y.), 2017-03, Vol.19 (3), p.175-184

2017

Volltextzugriff (PDF)

Clinical significance of heparanase splice variant (t5) in renal cell carcinoma: evaluation by a novel t5-specific monoclonal antibody

PloS one, 2012-12, Vol.7 (12), p.e51494-e51494

2012

Volltextzugriff (PDF)

Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5

Journal of leukocyte biology, 2005-02, Vol.77 (2), p.219-228

2005

Volltextzugriff (PDF)

The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action

Matrix biology, 2019-04, Vol.77, p.58-72

2019

Volltextzugriff (PDF)

Heparanase 2 Interacts with Heparan Sulfate with High Affinity and Inhibits Heparanase Activity

The Journal of biological chemistry, 2010-09, Vol.285 (36), p.28010-28019

2010

Volltextzugriff (PDF)

Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth

Cancer research (Chicago, Ill.), 2016-05, Vol.76 (9), p.2791-2801

2016

Volltextzugriff (PDF)

Heparanase 2 expression inversely correlates with bladder carcinoma grade and stage

Oncotarget, 2016-04, Vol.7 (16), p.22556-22565

2016

Volltextzugriff (PDF)

Structure-Function Approach Identifies a COOH-Terminal Domain That Mediates Heparanase Signaling

Cancer research (Chicago, Ill.), 2009-03, Vol.69 (5), p.1758-1767

2009

Volltextzugriff (PDF)

The prognostic significance of heparanase expression in metastatic melanoma

Oncotarget, 2016-11, Vol.7 (46), p.74678-74685

2016

Volltextzugriff (PDF)

Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer

Oncotarget, 2018-04, Vol.9 (27), p.19294-19306

2018

Volltextzugriff (PDF)

The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growth, Associating with Increased p21 Expression1

Neoplasia (New York, N.Y.), 2017-01, Vol.19 (3), p.175-184

2017

Volltextzugriff (PDF)

Human Cytomegalovirus Differentially Controls B Cell and T Cell Responses through Effects on Plasmacytoid Dendritic Cells

The Journal of immunology (1950), 2007-12, Vol.179 (11), p.7767-7776

2007

Volltextzugriff (PDF)

Clinical Significance of Heparanase Splice Variant

PloS one, 2012-12, Vol.7 (12), p.e51494

2012

Volltextzugriff (PDF)

Mast cells enhance eosinophil survival in vitro: role of TNF-alpha and granulocyte-macrophage colony-stimulating factor

The Journal of immunology (1950), 1998-06, Vol.160 (11), p.5554-5562

1998

Volltextzugriff (PDF)

Structure-function approach identifies a C-terminal domain that mediates heparanase signaling

Cancer research (Chicago, Ill.), 2009-02, Vol.69 (5), p.1758-1767

2009

Volltextzugriff (PDF)

Elimination of CD13 positive cells — an approach to prevent transmission of HCMV in bone marrow transplantation

Journal of clinical virology, 1999-04, Vol.12 (2), p.175-175

Feld, Sari

1999

Volltextzugriff (PDF)

Age‐related impaired affinity maturation and differential D‐JH gene usage in human VH6‐expressing B lymphocytes from healthy individuals

European journal of immunology, 1997-06, Vol.27 (6), p.1381-1386

1997

Volltextzugriff (PDF)

Increased Utilization of the VH6 Gene Family in Patients with Autoimmune Idiopathic Thrombocytopenic Purpura

Journal of autoimmunity, 1999-02, Vol.12 (1), p.57-63

1999

Volltextzugriff (PDF)

Altered VH6‐D‐JH repertoire in human insulin‐dependent diabetes mellitus and autoimmune idiopathic thrombocytopenic purpura

European journal of immunology, 1999-09, Vol.29 (9), p.2853-2862

1999

Volltextzugriff (PDF)

Aberrant V H Gene Utilization in Patients with Established Insulin-Dependent Diabetes Mellitus

Journal of autoimmunity, 1997-04, Vol.10 (2), p.157

1997

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Humans
(19)
Life Sciences & Biomedicine
(17)
Glucuronidase - Metabolism
(9)
Adult
(8)
Animals
(8)
Cell Line, Tumor
(8)
Female
(8)
Immunology
(8)
Oncology
(7)
Male
(6)
Metastasis
(6)
Mice
(6)
Middle Aged
(6)
Cell Biology
(5)
Glucuronidase - Antagonists & Inhibitors
(5)
Glucuronidase - Genetics
(5)
Heparanase
(5)
Medicin Och Hälsovetenskap
(5)
Aged
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis

Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications

Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2

Nuclear localization of heparanase 2 (Hpa2) attenuates breast carcinoma growth and metastasis

Heparanase facilitates cell adhesion and spreading by clustering of cell surface heparan sulfate proteoglycans

The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growth, Associating with Increased p21 Expression

Clinical significance of heparanase splice variant (t5) in renal cell carcinoma: evaluation by a novel t5-specific monoclonal antibody

Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5

The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action

Heparanase 2 Interacts with Heparan Sulfate with High Affinity and Inhibits Heparanase Activity

Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth

Heparanase 2 expression inversely correlates with bladder carcinoma grade and stage

Structure-Function Approach Identifies a COOH-Terminal Domain That Mediates Heparanase Signaling

The prognostic significance of heparanase expression in metastatic melanoma

Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer

The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growth, Associating with Increased p21 Expression1

Human Cytomegalovirus Differentially Controls B Cell and T Cell Responses through Effects on Plasmacytoid Dendritic Cells

Clinical Significance of Heparanase Splice Variant

Mast cells enhance eosinophil survival in vitro: role of TNF-alpha and granulocyte-macrophage colony-stimulating factor

Structure-function approach identifies a C-terminal domain that mediates heparanase signaling

Elimination of CD13 positive cells — an approach to prevent transmission of HCMV in bone marrow transplantation

Age‐related impaired affinity maturation and differential D‐JH gene usage in human VH6‐expressing B lymphocytes from healthy individuals

Increased Utilization of the VH6 Gene Family in Patients with Autoimmune Idiopathic Thrombocytopenic Purpura

Altered VH6‐D‐JH repertoire in human insulin‐dependent diabetes mellitus and autoimmune idiopathic thrombocytopenic purpura

Aberrant V H Gene Utilization in Patients with Established Insulin-Dependent Diabetes Mellitus

Suchergebnisse filtern